Moreover, our results showed that TRAF6 participated in the NF‐κB activation, which indicated that TRAF6 may play a key role in the CSC regulation through NF‐κB signalling in human SCCHN cells. Here, NFKB1 is linked to head and neck squamous cell carcinoma.